S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Financial Day of Reckoning Has Begun (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
High oil prices help Saudi Aramco earn $88B in first half
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Germans urged to cap heat in offices this winter to save gas
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Financial Day of Reckoning Has Begun (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
High oil prices help Saudi Aramco earn $88B in first half
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Germans urged to cap heat in offices this winter to save gas
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Financial Day of Reckoning Has Begun (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
High oil prices help Saudi Aramco earn $88B in first half
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Germans urged to cap heat in offices this winter to save gas
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
S&P 500   4,280.15
DOW   33,761.05
QQQ   330.39
Sinema took Wall Street money while killing tax on investors
The Financial Day of Reckoning Has Begun (Ad)
Expanded IRS free-file system one step closer in Dems' bill
Climate bill: Could coal communities shift to nuclear?
High oil prices help Saudi Aramco earn $88B in first half
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
Germans urged to cap heat in offices this winter to save gas
'Everyone's Got a Story of How the Healthcare System Has Fallen Short.' This Founder Is on a Mission to Change That.
Former Deutsche Bank Co-CEO Anshu Jain dies
Apple (AAPL) is making moves behind the scenes to prepare for a downturn... (Ad)
NYSE:A

Agilent Technologies - A Stock Forecast, Price & News

$133.55
+1.60 (+1.21%)
(As of 08/12/2022 12:00 AM ET)
Add
Compare
Today's Range
$131.43
$133.63
50-Day Range
$112.71
$134.56
52-Week Range
$112.52
$179.57
Volume
865,778 shs
Average Volume
1.29 million shs
Market Capitalization
$39.89 billion
P/E Ratio
32.18
Dividend Yield
0.63%
Price Target
$152.75

Agilent Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.69 Rating Score
Upside/​Downside
14.4% Upside
$152.75 Price Target
Short Interest
Healthy
1.01% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.14
Upright™ Environmental Score
News Sentiment
0.17mentions of Agilent Technologies in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$867,781 Sold Last Quarter
Proj. Earnings Growth
9.63%
From $4.88 to $5.35 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.99 out of 5 stars

Computer And Technology Sector

43rd out of 665 stocks

Analytical Instruments Industry

3rd out of 31 stocks

A stock logo

About Agilent Technologies (NYSE:A) Stock

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. StockNews.com upgraded Agilent Technologies from a "buy" rating to a "strong-buy" rating in a report on Wednesday, August 3rd. UBS Group assumed coverage on Agilent Technologies in a research note on Wednesday, July 20th. They issued a "buy" rating and a $139.00 price objective on the stock. The Goldman Sachs Group reduced their target price on Agilent Technologies from $170.00 to $140.00 and set a "buy" rating for the company in a research note on Thursday, July 14th. Robert W. Baird increased their price target on Agilent Technologies from $155.00 to $161.00 and gave the company an "outperform" rating in a research note on Wednesday, May 25th. Finally, Truist Financial downgraded Agilent Technologies from a "buy" rating to a "hold" rating in a report on Tuesday, April 19th. Four research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $152.75.

Agilent Technologies Trading Up 1.2 %

A traded up $1.60 during trading on Friday, reaching $133.55. 865,778 shares of the stock traded hands, compared to its average volume of 1,290,048. The company has a quick ratio of 1.49, a current ratio of 2.01 and a debt-to-equity ratio of 0.53. The stock's 50-day moving average is $123.11 and its 200 day moving average is $127.64. Agilent Technologies has a 12 month low of $112.52 and a 12 month high of $179.57. The stock has a market capitalization of $39.89 billion, a PE ratio of 32.18, a P/E/G ratio of 2.70 and a beta of 1.06.

Agilent Technologies (NYSE:A - Get Rating) last posted its quarterly earnings results on Tuesday, May 24th. The medical research company reported $1.13 EPS for the quarter, topping analysts' consensus estimates of $1.11 by $0.02. The business had revenue of $1.61 billion during the quarter, compared to analysts' expectations of $1.62 billion. Agilent Technologies had a net margin of 19.35% and a return on equity of 27.42%. The business's quarterly revenue was up 5.4% on a year-over-year basis. During the same period last year, the company posted $0.97 earnings per share. Equities analysts anticipate that Agilent Technologies will post 4.88 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, July 27th. Shareholders of record on Tuesday, July 5th were given a dividend of $0.21 per share. The ex-dividend date of this dividend was Friday, July 1st. This represents a $0.84 annualized dividend and a dividend yield of 0.63%. Agilent Technologies's dividend payout ratio is currently 20.24%.

Insiders Place Their Bets

In other news, VP Padraig Mcdonnell sold 1,000 shares of the company's stock in a transaction dated Thursday, June 30th. The stock was sold at an average price of $118.62, for a total transaction of $118,620.00. Following the sale, the vice president now directly owns 17,826 shares in the company, valued at $2,114,520.12. The sale was disclosed in a document filed with the SEC, which is available at this link. In other news, VP Padraig Mcdonnell sold 1,000 shares of the company's stock in a transaction on Thursday, June 30th. The shares were sold at an average price of $118.62, for a total value of $118,620.00. Following the transaction, the vice president now owns 17,826 shares of the company's stock, valued at $2,114,520.12. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, VP Jacob Thaysen sold 5,879 shares of Agilent Technologies stock in a transaction on Thursday, June 2nd. The shares were sold at an average price of $127.43, for a total value of $749,160.97. Following the sale, the vice president now directly owns 88,737 shares of the company's stock, valued at approximately $11,307,755.91. The disclosure for this sale can be found here.

Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

A Stock News Headlines

Fortive (FTV) Tops Q2 Earnings and Revenue Estimates
Agilent Technologies (NYSE:A) Shares Up 6.1%
Agilent Technologies (NYSE:A) Now Covered by UBS Group
Halo Labs Completes $6M Series C Growth Financing
See More Headlines
Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

A Company Calendar

Last Earnings
5/24/2022
Ex-Dividend for 7/27 Dividend
7/01/2022
Dividend Payable
7/27/2022
Today
8/14/2022
Next Earnings (Confirmed)
8/16/2022
Fiscal Year End
10/31/2022

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
00846U10
Employees
17,000
Year Founded
1999

Price Target and Rating

Average Stock Price Forecast
$152.75
High Stock Price Forecast
$185.00
Low Stock Price Forecast
$130.00
Forecasted Upside/Downside
+14.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.69
Research Coverage
13 Analysts

Profitability

Net Income
$1.21 billion
Pretax Margin
21.86%

Debt

Sales & Book Value

Annual Sales
$6.32 billion
Cash Flow
$5.47 per share
Book Value
$17.84 per share

Miscellaneous

Free Float
N/A
Market Cap
$39.89 billion
Optionable
Optionable
Beta
1.06

Social Links















A Stock - Frequently Asked Questions

Should I buy or sell Agilent Technologies stock right now?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 4 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" A shares.
View A analyst ratings
or view top-rated stocks.

What is Agilent Technologies' stock price forecast for 2022?

13 equities research analysts have issued 1 year price objectives for Agilent Technologies' shares. Their A share price forecasts range from $130.00 to $185.00. On average, they predict the company's stock price to reach $152.75 in the next twelve months. This suggests a possible upside of 14.4% from the stock's current price.
View analysts price targets for A
or view top-rated stocks among Wall Street analysts.

How have A shares performed in 2022?

Agilent Technologies' stock was trading at $159.65 on January 1st, 2022. Since then, A stock has decreased by 16.3% and is now trading at $133.55.
View the best growth stocks for 2022 here
.

Are investors shorting Agilent Technologies?

Agilent Technologies saw a decline in short interest during the month of July. As of July 31st, there was short interest totaling 3,010,000 shares, a decline of 6.5% from the July 15th total of 3,220,000 shares. Based on an average daily trading volume, of 1,640,000 shares, the short-interest ratio is currently 1.8 days. Approximately 1.0% of the company's stock are sold short.
View Agilent Technologies' Short Interest
.

When is Agilent Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 16th 2022.
View our A earnings forecast
.

How can I listen to Agilent Technologies' earnings call?

Agilent Technologies will be holding an earnings conference call on Tuesday, August 16th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) issued its quarterly earnings results on Tuesday, May, 24th. The medical research company reported $1.13 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.11 by $0.02. The medical research company earned $1.61 billion during the quarter, compared to analyst estimates of $1.62 billion. Agilent Technologies had a trailing twelve-month return on equity of 27.42% and a net margin of 19.35%. Agilent Technologies's revenue for the quarter was up 5.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.97 earnings per share.
Read the conference call transcript
.

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies declared a quarterly dividend on Wednesday, May 18th. Investors of record on Tuesday, July 5th will be given a dividend of $0.21 per share on Wednesday, July 27th. This represents a $0.84 annualized dividend and a dividend yield of 0.63%. The ex-dividend date of this dividend is Friday, July 1st.
Read our dividend analysis for A
.

Is Agilent Technologies a good dividend stock?

Agilent Technologies (NYSE:A) pays an annual dividend of $0.84 per share and currently has a dividend yield of 0.64%. The company has been increasing its dividend for 11 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 20.24%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 15.70% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

How will Agilent Technologies' stock buyback program work?

Agilent Technologies declared that its Board of Directors has initiated a stock repurchase program on Tuesday, February 16th 2021, which permits the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to purchase up to 5% of its stock through open market purchases. Stock buyback programs are usually a sign that the company's management believes its stock is undervalued.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies issued an update on its FY 2022 earnings guidance on Tuesday, June, 21st. The company provided EPS guidance of $4.86-$4.93 for the period, compared to the consensus EPS estimate of $4.60. The company issued revenue guidance of $6.67 billion-$6.73 billion, compared to the consensus revenue estimate of $6.36 billion.

What is Mike McMullen's approval rating as Agilent Technologies' CEO?

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

What is Agilent Technologies' stock symbol?

Agilent Technologies trades on the New York Stock Exchange (NYSE) under the ticker symbol "A."

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Massachusetts Financial Services Co. MA (1.96%), Pictet Asset Management SA (1.83%), Northern Trust Corp (1.41%), Cantillon Capital Management LLC (1.16%), FMR LLC (1.14%) and Principal Financial Group Inc. (1.04%). Insiders that own company stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Jacob Thaysen, Mark Doak, Michael R Mcmullen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Rodney Gonsalves and Samraat S Raha.
View institutional ownership trends
.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Agilent Technologies' stock price today?

One share of A stock can currently be purchased for approximately $133.55.

How much money does Agilent Technologies make?

Agilent Technologies (NYSE:A) has a market capitalization of $39.89 billion and generates $6.32 billion in revenue each year. The medical research company earns $1.21 billion in net income (profit) each year or $4.15 on an earnings per share basis.

How many employees does Agilent Technologies have?

The company employs 17,000 workers across the globe.

Does Agilent Technologies have any subsidiaries?

The following companies are subsidiares of Agilent Technologies: ACEA BIO, ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Singapore (Global) Pte Ltd., Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako Denmark, Dako Denmark ApS, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.
Read More

When was Agilent Technologies founded?

Agilent Technologies was founded in 1999.

How can I contact Agilent Technologies?

Agilent Technologies' mailing address is 5301 STEVENS CREEK BLVD, SANTA CLARA CA, 95051. The official website for the company is www.agilent.com. The medical research company can be reached via phone at (800) 227-9770, via email at investor_relations@agilent.com, or via fax at 408-345-8474.

This page (NYSE:A) was last updated on 8/14/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.